🔎 Trials Near Me

Gara Jalqabaatti › Myeloma Baay’ee

Qorannoo klinikaalii Myeloma Baay’ee Ameerikaa Keessatti hirmaatuu

Qorannoo 239 Myeloma Baay’ee f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06976476

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06465316

Limited-duration Teclistamab

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05932680

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06904066

A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06679829

SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07850284

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05652335

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT02682667

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 72 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT03412877

Tissue Collection for Studies of Lymph Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT01676805

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05201781

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07149857

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07258511

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.